On Jun. 15, 2026, Johnson & Johnson announced an investment of more than $1 billion in Jacksonville, Florida to strengthen its Vision operations by scaling U.S.-based manufacturing, packaging and distribution capabilities.

The investment includes construction of a new, state-of-the-art distribution facility, alongside advanced manufacturing and packaging technologies to expand capacity and meet growing demand for the Company’s market-leading ACUVUE®-brand contact lenses. These enhancements further strengthen the Company’s leadership in delivering high-quality, innovative eye health solutions, helping to improve sight for more than 40 million patients in the U.S. and around the world.

The announcement was part of the Company’s previously announced $55 billion U.S. investment in manufacturing, research and development, and technology through early 2029. Construction of the new facility is underway with the goal of being fully operational in 2028.

For more than four decades, Johnson & Johnson’s Jacksonville operations have advanced eye health through innovative optical solutions, helping transform how people see and experience the world. Today, Johnson & Johnson manufactures more than 1.7 billion ACUVUE® contact lenses annually for U.S. patients.

Since establishing its Jacksonville presence in 1981, the Company has built a strong foundation for economic growth in the region. Today, Johnson & Johnson contributes approximately $6 billion annually to Florida’s economy, supported by more than 1.5 million square feet of manufacturing, research, distribution, and operations facilities.